Log in
Email Address
Password
Forgot your password?
Not Registered?

Blog Spot

SMWcroppednew

Name: Stewart Watkins, Managing Director

Company: CDDC

PETEC, owned and managed by the Centre for Process Innovation (CPI), is the national flagship facility for the development and exploitation of direct write technologies and flexible functional materials. It is one of only four such centres in the world.

Click here to read the full blog

Featured Tenant

deburca


deBurca is a software development and integration company that specialises in creating, implementing and supporting innovative applications for e-learning and eBusiness.

Click here to learn more about deBurca

Featured Opportunity
An Improved Microgripper for Cell Manipulation.

There is a growing need for individual cell manipulation in a wide range of research applications including stem cell sorting, gene and molecular delivery, cellular diagnostics, and single cell-based assays.

For further information click here

Polls



CDEP logo Durham County Council Logo

cddc European Union emblem


Oneaboutnetparknet logo


NETPark Net has received funding from Durham County Council through County Durham Development Company, and One NorthEast through the County Durham Sub Regional Partnership. Project Part-Financed by the European Union. European Regional Development Fund.

Gene therapy could cure deafness


Bookmark and Share Add This     Email notification Email a Friend    print Printable version

Gene therapy could cure deafness

2008-08-28
Newsfeed

Innovative genetic engineering by US scientists could eventually lead to a cure for deafness, it has been revealed.


Innovative genetic engineering by US scientists could eventually lead to a cure for deafness, it has been revealed.

Tiny hairs found in the inner ear, which are vital to hearing, have been regrown through gene therapy in the ears of mice.

The cochlea hairs translate sound waves into nerve messages so if they are lost or damaged, hearing may be irrevocably impaired.

This is an early step towards curing deafness as mammals are not normally able to regenerate the hairs, but this obstacle could be overcome by genetic engineering.

The US researchers led by Dr John Brigande, from Oregon Health and Science University in Portland, inserted a gene called Atoh 1, which activates cochlea hair development, into mice while they were still developing in the womb. This created non-sensory cells in the inner ear to become hair cells. Cochlea hairs became technically functional as they attached to nerve fibres during tests.

The scientists wrote in the journal Nature that the success of the tests may lead to the design and functional assessment of gene therapies aimed at curing human deafness and balance disorders. They said it is a crucial first step in defining therapies for inner ear disease in humans.

Copyright © The Press Association 2008